Effects of liraglutide and semaglutide on stroke subtypes in patients with type 2 diabetes: a post hoc analysis of the LEADER, SUSTAIN 6 and PIONEER 6 trials

被引：0
|
作者：
Strain, W. D. [1 ]
Holst, A. G. [2 ]
Rasmussen, S. [2 ]
Saevereid, H. A. [2 ]
James, M. A. [1 ]
机构：
[1] Univ Exeter, Sch Med, Diabet & Vasc Res Ctr, Exeter, Devon, England
[2] Novo Nordisk AS, Soborg, Denmark
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
258
引用
收藏
页码：S130 / S131
页数：2
相关论文
共 50 条
  • [41] Efficacy and safety of oral semaglutide in Japanese patients with type 2 diabetes: A post hoc subgroup analysis of the PIONEER 1, 3, 4 and 8 trials
    Araki, Eiichi
    Terauchi, Yasuo
    Watada, Hirotaka
    Deenadayalan, Srikanth
    Christiansen, Erik
    Horio, Hiroshi
    Kadowaki, Takashi
    DIABETES OBESITY & METABOLISM, 2021, 23 (12): : 2785 - 2794
  • [42] Efficacy and safety of semaglutide in elderly subjects with type 2 diabetes: a post hoc analysis of the SUSTAIN 7 trial
    Aroda, V. R.
    Sugimoto, D.
    Trachtenbarg, D.
    Warren, M.
    Navarria, A.
    Nayak, G.
    Nielsen, M. Abildlund
    Woo, V.
    DIABETOLOGIA, 2018, 61 : S367 - S367
  • [43] EFFECTS OF THE GLUCAGON-LIKE PEPTIDE-1 (GLP-1) ANALOGUES SEMAGLUTIDE AND LIRAGLUTIDE ON RENAL OUTCOMES - A POOLED ANALYSIS OF THE SUSTAIN 6 AND LEADER TRIALS
    Perkovic, Vlado
    Bain, Stephen
    Bakris, George
    Buse, John
    Idorn, Thomas
    Mahaffey, Kenneth
    Marso, Steven
    Nauck, Michael
    Pratley, Richard
    Rasmussen, Soren
    Rossing, Peter
    Tornoe, Karen
    Zinman, Bernard
    Mann, Johannes
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2019, 34 : 338 - 338
  • [44] Impact of microvascular disease on cardiorenal outcomes in type 2 diabetes: an analysis from the LEADER and SUSTAIN 6 clinical trials
    Zinman, B.
    Verma, S.
    Bain, S. C.
    Honore, J. B.
    Mann, J.
    Nauck, M. A.
    Pratley, R.
    Rasmussen, S.
    Ripa, M. Sejersten
    Buse, J. B.
    DIABETOLOGIA, 2019, 62 : S365 - S366
  • [45] Efficacy and safety of once-weekly semaglutide in elderly subjects with type 2 diabetes: post hoc analysis of SUSTAIN 1-5 trials
    Warren, M.
    Chaykin, L.
    Trachtenbarg, D.
    Nayak, G.
    Wijayasinghe, N.
    Cariou, B.
    DIABETOLOGIA, 2017, 60 : S378 - S379
  • [46] Effects of once-weekly subcutaneous semaglutide on kidney function and safety in patients with type 2 diabetes: a post-hoc analysis of the SUSTAIN 1-7 randomised controlled trials
    Mann, Johannes F. E.
    Hansen, Thomas
    Idorn, Thomas
    Leiter, Lawrence A.
    Marso, Steven P.
    Rossing, Peter
    Seufert, Jochen
    Tadayon, Sayeh
    Vilsboll, Tina
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11): : 880 - 893
  • [47] IMPACT OF MICROVASCULAR DISEASE ON CARDIORENAL OUTCOMES IN TYPE 2 DIABETES: AN ANALYSIS FROM THE LEADER AND SUSTAIN-6 CLINICAL TRIALS
    Verma, Subodh
    Bain, Stephen C.
    Honore, Julie Broe
    Mann, Johannes F. E.
    Nauck, Michael A.
    Pratley, Richard E.
    Rasmussen, Soren
    Ripa, Maria Sejersten
    Zinman, Bernard
    Buse, John
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2019, 73 (09) : 1687 - 1687
  • [48] Effects of Liraglutide on Cardiovascular Outcomes in Type 2 Diabetes Patients With and Without Baseline Metformin Use: Post Hoc Analyses of the LEADER Trial
    Crowley, Matthew J.
    McGuire, Darren K.
    Alexopoulos, Anastasia-Stefania
    Jensen, Thomas Jon
    Rasmussen, Soren
    Saevereid, Hans A.
    Verma, Subodh
    Buse, John B.
    DIABETES CARE, 2020, 43 (09) : E108 - E110
  • [49] The importance of addressing multiple risk markers in type 2 diabetes: Results from the LEADER and SUSTAIN 6 trials
    Zobel, Emilie H.
    von Scholten, Bernt Johan
    Hansen, Tine W.
    Persson, Frederik
    Rasmussen, Soren
    Wolthers, Benjamin
    Rossing, Peter
    DIABETES OBESITY & METABOLISM, 2022, 24 (02): : 281 - 288
  • [50] THE IMPORTANCE OF ADDRESSING MULTIPLE RISK MARKERS IN TYPE 2 DIABETES: RESULTS FROM THE LEADER AND SUSTAIN 6 TRIALS
    Zobel, Emilie
    Von Scholten, Bernt Johan
    Hansen, Tine
    Persson, Frederik
    Rasmussen, Soren
    Wolthers, Benjamin
    Rossing, Peter
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2021, 36
12345